JP2002510489A - 高活性型インターフェロン調節因子タンパク質 - Google Patents

高活性型インターフェロン調節因子タンパク質

Info

Publication number
JP2002510489A
JP2002510489A JP2000542450A JP2000542450A JP2002510489A JP 2002510489 A JP2002510489 A JP 2002510489A JP 2000542450 A JP2000542450 A JP 2000542450A JP 2000542450 A JP2000542450 A JP 2000542450A JP 2002510489 A JP2002510489 A JP 2002510489A
Authority
JP
Japan
Prior art keywords
irf
protein
ser
modified
interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000542450A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002510489A5 (https=
Inventor
ジョン、ヒスコット
ロングトゥアン、リン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jewish General Hospital
Original Assignee
Jewish General Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jewish General Hospital filed Critical Jewish General Hospital
Publication of JP2002510489A publication Critical patent/JP2002510489A/ja
Publication of JP2002510489A5 publication Critical patent/JP2002510489A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2000542450A 1998-04-07 1999-04-07 高活性型インターフェロン調節因子タンパク質 Pending JP2002510489A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,234,588 1998-04-07
CA002234588A CA2234588A1 (en) 1998-04-07 1998-04-07 Virus induced phosphorylation of interferon regulatory factor-3
PCT/CA1999/000314 WO1999051737A1 (en) 1998-04-07 1999-04-07 Highly active forms of interferon regulatory factor proteins

Publications (2)

Publication Number Publication Date
JP2002510489A true JP2002510489A (ja) 2002-04-09
JP2002510489A5 JP2002510489A5 (https=) 2006-06-15

Family

ID=4162326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000542450A Pending JP2002510489A (ja) 1998-04-07 1999-04-07 高活性型インターフェロン調節因子タンパク質

Country Status (6)

Country Link
EP (1) EP1068314A1 (https=)
JP (1) JP2002510489A (https=)
AU (1) AU3324899A (https=)
CA (1) CA2234588A1 (https=)
IL (1) IL138921A0 (https=)
WO (1) WO1999051737A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920906D0 (en) * 1999-09-03 1999-11-10 Glaxo Group Ltd Increased production of interferon-a

Also Published As

Publication number Publication date
WO1999051737A1 (en) 1999-10-14
EP1068314A1 (en) 2001-01-17
CA2234588A1 (en) 1999-10-07
IL138921A0 (en) 2001-11-25
AU3324899A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
Lin et al. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation
Novoa et al. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α
Sangfelt et al. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines
Saller et al. Increased apoptosis induction by 121F mutant p53
Pitha et al. Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth
US5656725A (en) Peptides and compositions which modulate apoptosis
Morin et al. Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription
US5731155A (en) Compositions for inhibition of intracellular transcription factors and methods therefor
US20110182811A1 (en) Nucleotide sequence encoding a modulator of nf-kb
US7358088B2 (en) Peptides and compositions which modulate apoptosis
US20130330738A1 (en) Sumoylation Control Agent and Uses Thereof
JP2002510489A (ja) 高活性型インターフェロン調節因子タンパク質
WO2001068846A2 (en) Transcription activator of the cited family
Kong et al. Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer‐amplified transcription coactivator ASC‐2
CA2132317A1 (en) Ifn receptors recognition factors, protein sequences and methods of use thereof
CA2325354A1 (en) Highly active forms of interferon regulatory factor proteins
US20050260582A1 (en) Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
US6890743B2 (en) Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses
WO2000073467A1 (en) Snf2 related cbp activator protein (srcap)
Eloranta Regulation of the human beta-interferon promoter
O'Rourke Jr Expression, function and transcriptional regulation of the CCAAT/enhancer binding protein delta (C/EBP (delta)) in mouse mammary epithelial cells
Sharma I Kappa B kinases control virus activation of interferon regulatory factor signaling
Kwon Mutants of I [kappa] B [alpha] Interfere with NF-[kappa] B Regulated Gene Expression and HIV-1 Replication
Zhu Class II transactivator (CIITA): Its associative properties and regulatory functions
Nguyen-Raymond Regulation of gene expression and cell growth by transcriptional proteins of the interferon system.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060407

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090619

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091117